RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 250 participants.
Also called NCT07696975
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 250 participants
- Sponsor
- Registry
-
NCT07696975
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07696975. Randomized; quadruple masking; primary purpose treatment. Start 2027-07-01 (anticipated); primary completion 2030-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF
- Acronym
- RELIEVE-HFrEF
- Condition
- Heart Failure and Reduced Ejection Fraction
- Condition
- Heart Failure Chronic
- Condition
- Heart Failure New York Heart Association Class III
- Condition
- Heart Failure Congestive
- Intervention (Device)
- Implantation of the V-Wave Interatrial shunt
- Intervention (Device)
- Sham (no implant)
- Lead sponsor
- V-Wave Ltd
- Collaborator
- Johnson & Johnson
Record details
- Record id
cardio:ct-nct07696975- Content hash
6cdd43e3f61bc5bf90a20c5e0eca724eade105f41fbd43f9a9f18dad160d8037